Literature DB >> 1809196

High cell density fermentation of recombinant Escherichia coli with computer-controlled optimal growth rate.

W A Knorre1, W D Deckwer, D Korz, H D Pohl, D Riesenberg, A Ross, E Sanders, V Schulz.   

Abstract

In recent years recombinant DNA technology has enabled us to produce various proteins of therapeutic importance with microorganisms. As an appropriate host organism, E. coli plays a dominant role. Yields of E. coli dry cell mass in shaker flask culture range from 1-2 g/L, whereas in fermentors up to 10 g dry cells/L can be achieved. ZIMET and GBF have developed a high cell density fermentation process that produces E. coli (on a glucose/mineral salt medium) up to more than 100 g dry cells/L in a special fed-batch mode. This cultivation strategy prevents oxygen limitation and hence the accumulation of acetate and other metabolic byproducts. The specific growth rate can be adjusted so that product formation reaches its optimum value. An example of the production of alpha1-interferon is presented. The high cell density fermentations were realized in 30- and 450-L Chemap fermentors (ZIMET) and in a three-stage bioreactor scale-up system (72, 300, and 1,500 L) developed in cooperation with GBF and B. Braun Melsungen AG. Multiloop controllers were used to control the process variables.

Entities:  

Mesh:

Year:  1991        PMID: 1809196     DOI: 10.1111/j.1749-6632.1991.tb18592.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  2 in total

1.  Development of a versatile computer integrated control system for bioprocess controls.

Authors:  D Kong; R Gentz; J Zhang
Journal:  Cytotechnology       Date:  1998-05       Impact factor: 2.058

2.  Efficient brazzein production in yeast (Kluyveromyces lactis) using a chemically defined medium.

Authors:  Se-Woong Park; Byung-Ha Kang; Hyeong-Min Lee; Sung-Jun Lee; Han-Seul Kim; Hye-Won Choi; Tae Jung Park; Kwang-Hoon Kong
Journal:  Bioprocess Biosyst Eng       Date:  2021-01-27       Impact factor: 3.210

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.